TAK Takeda Pharmaceutical Company Limited ADRs

Takeda Pharmaceutical Co Ltd is a pharmaceutical company in Japan. It is primarily focused on four therapeutic areas; oncology, gastroenterology, cardiovascular/metabolic, and neurology. The company markets its products across Europe and emerging markets. This is an ADR of a company whose stock trades outside of the U.S. as the symbol JT:4502.

$14.30  -0.22 (-1.52%)
As of 01/26/2022 16:00:02 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Japan
Country of incorporation:  
IPO date:  04/26/2000
Outstanding shares:  3,164,505,050
Average volume:  3,657,164
Market cap:   $45,822,033,124
Current dividend yield:  5.48%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      
Valuation   (See tab for details)
PE ratio:   10.97
PB ratio:   0.01
PS ratio:   1.54
Return on equity:   8.89%
Net income %:   13.91%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy